Simplex Trading
TNGX icon

Simplex Trading’s Tango Therapeutics TNGX Stock Holding History

Simplex Trading’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800
Closed -$16.7K – 10315
2026
Q1 		$16.7K Buy
800
+400
+100% +$5.57K ﹤0.01% 6906
2025
Q4 		$3.54K Sell
400
-2,600
-87% -$22.4K ﹤0.01% 7608
2025
Q3 		$25K Buy
+3,000
New +$20.3K ﹤0.01% 7154
2024
Q4 		– Sell
-700
Closed -$5K – 9639
2024
Q3 		$5K Buy
+700
New +$6.68K ﹤0.01% 7650

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's TNGX Position: Q2 2026 in Review

Simplex Trading reduced its Tango Therapeutics (TNGX) stake by 15% in Q2 2026, selling an estimated $3.81K and leaving 902 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6813.

Simplex Trading first reported a position in TNGX in Q4 2023 and has held it in 5 quarters since. The position peaked at $255K in Q2 2025. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Simplex Trading held 902 shares of Tango Therapeutics worth $28.2K as of Q2 2026.
  • Simplex Trading sold 154 Tango Therapeutics shares in Q2 2026, an estimated $3.81K.
  • Tango Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6813 holding.
  • Simplex Trading first reported a position in Tango Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Simplex Trading's Tango Therapeutics position peaked at $255K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.